Oticon Intent vs Signia Pure C&G IX

The Oticon Intent is a premium behind-the-ear prescription hearing aid released in 2024, priced at $4,898. With a SoundScore of 4.8/5 and an A grade, it ranks #3 among the 36 prescription hearing aids tested by HearAdvisor, placing it in the top 6% of its category. In our lab testing, the Intent delivers strong speech performance, scoring 1.10 points above the category average for speech in noise and 0.62 points above average for speech in quiet. Music streaming is a particular strength at 4.0/5, which is 1.36 points above the prescription hearing aid average—making it a solid choice for users who frequently stream audio from their phones. Feedback handling is excellent at 5.0/5, ensuring stable performance without whistling during everyday activities. The most notable limitation is own-voice comfort, which scores 1.3/5—a low result that falls 1.45 points below the category average. Users sensitive to how their own voice sounds while wearing hearing aids should be aware of this trade-off. The Intent includes rechargeable batteries, both iPhone and Android streaming, and hands-free calling capabilities. It has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024. This hearing aid is best suited for users prioritizing speech clarity in challenging listening environments and high-quality audio streaming, who can accept the own-voice characteristics. Within its premium price tier, competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Real (4.75/5) offer alternatives worth considering.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.